(Q45882718)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Niels Schaft

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jan Dörrie

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

K Birkholz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A Hombach

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C Krug

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S Reuter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

E Kämpgen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

G Schuler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

H Abken

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

22 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

596-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

Cancer despite immunosurveillance: immunoselection and immunosubversion

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Exploiting T cell receptor genes for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

T-cell activation by recombinant immunoreceptors: impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

21 January 2018

Carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Gene therapy for SCID--a complication after remarkable progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Resistance of mature T cells to oncogene transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

ErbB-directed immunotherapy: antibodies in current practice and promising new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

Improving T cell therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

The T-body approach: redirecting T cells with antibody specificity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Safety of retroviral gene marking with a truncated NGF receptor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.189

7 January 2021

Identifiers

DOI

10.1038/GT.2008.189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19158846%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 January 2020

1023978429

0 references

1 reference